China Regenerative Medicine International Ltd. | |
Stock Exchange | Hong Kong Stock Exchange |
EPS |
HKD1.36 |
Market Cap |
HKD161.79 M |
Shares Outstanding |
17.59 B |
Public Float |
8.66 B |
Address |
Rooms 3006-10, 30/F Hong Kong Hong Kong |
Employees | - |
Website | http://www.crmi.hk |
Updated | 07/08/2019 |
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development, production and sales of tissue engineering and regenerative medicine products. It operates through the following business segments: Tissue Engineering, Cell, and Cosmetic and Others, and Medical Equipment. The Tissue Engineering segment produces and sells tissue. |